First Light Asset Management’s AstraZeneca AZN Stock Holding History

First Light Asset Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-5,680	Closed	-$373K	–	57
2016 Q3	$373K	Hold	5,680	–	–	0.16%	57
2016 Q2	$343K	Hold	5,680	–	–	0.16%	60
2016 Q1	$320K	Hold	5,680	–	–	0.16%	60
2015 Q4	$386K	Hold	5,680	–	–	0.16%	57
2015 Q3	$361K	Hold	5,680	–	–	0.18%	53
2015 Q2	$362K	Hold	5,680	–	–	0.17%	56
2015 Q1	$389K	Hold	5,680	–	–	0.2%	53
2014 Q4	$400K	Hold	5,680	–	–	0.23%	54
2014 Q3	$406K	Hold	5,680	–	–	0.28%	50
2014 Q2	$422K	Hold	5,680	–	–	0.28%	51
2014 Q1	$369K	Hold	5,680	–	–	0.26%	57
2013 Q4	$337K	Buy	+5,680	New	+$309K	0.29%	55

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

First Light Asset Management's AZN Position: Q4 2016 in Review

First Light Asset Management sold out of AstraZeneca (AZN) in Q4 2016, closing a stake of 5,680 shares — an estimated $373K sold.

First Light Asset Management first reported a position in AZN in Q4 2013 and held it in 12 quarters. The position peaked at $422K in Q2 2014. 450 funds tracked by Wall St. Rank hold AZN as of Q4 2016.

First Light Asset Management reported no remaining AstraZeneca position as of Q4 2016 after selling out during the quarter.
First Light Asset Management sold 5,680 AstraZeneca shares in Q4 2016, an estimated $373K.
First Light Asset Management first reported a position in AstraZeneca in Q4 2013 and held it in 12 quarters.
First Light Asset Management's AstraZeneca position peaked at $422K in Q2 2014.
450 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2016.

Based on First Light Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.